COL17A1 and bullous pemphigoid: IgE autoantibodies in pemphigoid disease were mainly reported to target the N-terminal ectodomain of BP180 or BP230 in patients with bullous pemphigoid, a pemphigoid diseases not associated with scar formation and a low rate of mucosal lesions (67–71).